Avis Sur Les Aspects Éthiques de la Brevetabilité Des Inventions Impliquant Des Cellules Souches Humaines


Book Description

Recoge : 1. The text of the opinion no 16. - 2. The patentability in the european union. - 3. The patentability in the United States. - 4. The european patent office. - 5. World trade organisation. - 6.World intellectual property organisation. - 7. Point of view from an industrial representative. - 8. Annex.










Dealmaking


Book Description

Applying practical tools to the volatile process of negotiating Prognosticators apply Monte Carlo Analysis (MCA) to determine the likelihood and significance of a complete range of future outcomes; Real Options Analysis (ROA) can then be employed to develop pricing structures, or options, for such outcomes. Richard Razgaitis' Dealmaking shows readers how to apply these powerful valuation tools to a variety of business processes, such as pricing, negotiating, or living with a "deal," be it a technology license, and R&D partnership, or an outright sales agreement. Dealmaking distinguishes itself from other negotiating guides not only by treating negotiations as an increasingly common situation, but also by presenting a tool-based approach that creates flexible, practical valuation models. This forward-thinking guide includes a variety of checklists, case studies, and a CD-ROM with the appropriate software. Richard Razgaitis (Bloomsbury, NJ) is a Managing Director at InteCap, Inc. He has over twenty-five years of experience working with the development, commercialization, and strategic management of technology, seventeen of which have been spent in the commercialization of intellectual property.




Biowarfare in America


Book Description

The era of chemical and biological megadeath is upon us, and the potential of deadly biowarfare attacks from governments, militant independent groups, and even individuals is far greater than it has been at any time in the past. At this time, more than twenty-five countries are developing, or have stockpiles of chemical and biological weapons, in many cases in sufficient quantities to wipe out the entire population of the world. So far the danger of chemical and biological aggression has been little acknowledged, and, at least in America, little prepared for by federal and local government. Most terrorist threats and attacks are not widely reported in the mainstream media. Although information about the proliferation of man-made diseases is carefully suppressed by governments and the media they will be covered in the pages of this book. Not only is America unprepared and ignorant of what is happening, but the people in government and scientific professions who do know, who should be warning the American public about the dangers of chemical and biological terrorism, are instead doing their utmost to hide this information from us; information that is vital for our survival.The information that is contained in the pages of this book will not be measured or calculated to reassure people that everything is fine, when reassurance is the exact opposite of what is needed at this time. It may even give you nightmares when you realise the real circumstance that we are in. The information in the pages that follow will be the truth about the biowarfare threat to America.




Managing epidemics: key facts about major deadly diseases


Book Description

Epidemics and pandemics of infectious diseases are occurring more often, and spreading faster and further than ever, in many different regions of the world. The background factors of this threat are biological, environmental and lifestyle changes, among others. A potentially fatal combination of newly-discovered diseases, and the re-emergence of many long-established ones, demands urgent responses in all countries. Planning and preparation for epidemic prevention and control are essential. The purpose of the Managing epidemics handbook is to provide expert guidance on those response. Building on the first edition, the second edition provides concise and basic up-to-date knowledge with which World Health Organization country representatives can advise Ministries of Health to respond effectively and rapidly at the very start of an outbreak. Part I of the handbook provides insights on epidemics of the 21st century and offers context on the upsurge of recent epidemics. Part II has been updated and offers 10 key facts about 19 deadly diseases including tips on the interventions required to respond. Part III presents various Tool boxes that summarize guidance on several important topics. The handbook focuses on practical and indispensable things to know about infectious diseases that are most important for national, political and operational decision-makers; it also links readers to more exhaustive WHO guidance.




Biomimicry


Book Description

Repackaged with a new afterword, this "valuable and entertaining" (New York Times Book Review) book explores how scientists are adapting nature's best ideas to solve tough 21st century problems. Biomimicry is rapidly transforming life on earth. Biomimics study nature's most successful ideas over the past 3.5 million years, and adapt them for human use. The results are revolutionizing how materials are invented and how we compute, heal ourselves, repair the environment, and feed the world. Janine Benyus takes readers into the lab and in the field with maverick thinkers as they: discover miracle drugs by watching what chimps eat when they're sick; learn how to create by watching spiders weave fibers; harness energy by examining how a leaf converts sunlight into fuel in trillionths of a second; and many more examples. Composed of stories of vision and invention, personalities and pipe dreams, Biomimicry is must reading for anyone interested in the shape of our future.




OECD Science, Technology and Industry Scoreboard 2001


Book Description

Are OECD countries becoming more knowledge-based? Are they embracing the information economy? To what extent are innovation, science, technology and economies becoming global? What are the new growth industries and occupations? With over 160 indicators, 60% of them new to this edition, the volume provides a comprehensive picture of countries’ performance in the areas of science, technology and industry. It uses an improved classification of technology and knowledge-intensive industries. New indicators address emerging policy issues: international mobility of human capital, relative innovative performance as measured by patent families, skills in the information economy, diffusion of the Internet and electronic commerce. Resources devoted to innovation in emerging areas such as biotechnology, environment, health and information and communication technologies are measured for the first time. A new section on the information economy relies on the latest data from official sources. With the essential findings presented in bullet points and methodological notes on indicators and data sources, this publication combines statistical rigour with easy access and readability. An electronic version makes individual sections, an elaborate data appendix and links to the databases readily available. The electronic version also gives users “clickable” access to the data used in charts and figures. AREAS COVERED: New resources for the knowledge-based economy - Human capital and international mobility - R&D performance - Role of government and business in R&D and innovation - Science and innovation performance - Resources and infrastructure for the information economy - Diffusion of Internet technologies and electronic commerce - Contribution of the information and communication technologies to economic performance - International trade - Foreign direct investment - Strategic alliances and cross-border, mergers and acquisitions - Internationalisation of science and technology - Industrial structure and productivity growth - Technology and knowledge-intensive industries and their performance. FURTHER READING: OECD Science, Technology and Industry Outlook 2000; OECD Information Technology Outlook 2000; OECD Communications Outlook 2001; A New Economy: Beyond the Hype, 2001 (OECD ); OECD Main Science and Technology Indicators 2001/1 and STI Working Papers series available at http://www.oecd.org/dsti/sti/stat-ana/index.htm.







The Great Cholesterol Con


Book Description

Statins are widely prescribed to lower blood cholesterol levels and claim to offer unparalleled protection against heart disease. Believed to be completely safe and capable of preventing a whole series of other conditions, they are the most profitable drug in the history of medicine. In this groundbreaking book, GP Malcolm Kendrick exposes the truth behind the hype. He will change the way we think about cholesterol forever. Rubbishing the diet-heart hypothesis, in which clinical trials 'prove' that high cholesterol causes heart disease and a high-fat diet leads to heart disease, Kendrick lambastes a powerful pharmaceutical industry and unquestioning medical profession, who, he claims, perpetuate the madcap concepts of 'good' and 'bad' cholesterol and cholesterol levels to convince millions of people to unnecessarily spend billions of pounds on statins. Clearly and comprehensively debunking assumptions on what constitute a healthy lifestyle and diet, "The Great Cholesterol Con" is the accessible, indispensable and absorbing case against statins and for a more common-sense approach to heart disease and general wellbeing. No more over-hyped miracle drugs; no more garlic, red wine, anti-oxidants, fruit or vegetables; even a vegetarian diet is rejected in this controversial yet authoritative critique of how we have been mislead over how food and drugs affect our coronary health. Here, for the first time, is the invaluable guide for anyone who though there was a miracle cure for heart disease, "The Great Cholesterol Con" is a fascinating breakthrough that will set dynamite under the whole area.